Skip to content
2000
image of Genetic, Cytogenetic and Hematological Features in Newly Diagnosed Acute Lymphoid Leukemia Patients under Eighteen Years Age Rreferred to Ali Asghar Hospital of Tehran, Iran, from 2013 to 2023

Abstract

Introduction

Acute lymphoblastic leukemia (ALL), a hematopoietic cancer of T or B lymphoblasts, is the most prevalent cancer in children. Ongoing research aims to better understand the factors contributing to ALL and create more successful treatment options. Therefore, the current study presented cytogenetic, genetic, and hematologic features from 318 ALL patients under eighteen years of age who were referred to Ali Asghar Hospital of Tehran, Iran, from 2013 to 2023.

Methods

This study was designed as a retrospective cross-sectional analysis, focusing on 318 children in Tehran, Iran, who had been newly diagnosed with ALL. All data were extracted from the patient case files that included additional information, such as clinical data, and demographic information. The Flow cytometry technique was employed to perform immunophenotyping for various markers. Moreover, the standardized protocol was carried out for conventional cytogenetic analysis.

Results

Out of 318, 179 (56.3%) and 139 (43.7%) were males and females, respectively. The most common subtype of ALL was Common B Cell ALL, accounting for 182 cases (57.23%), followed by Pre B cell ALL with 74 cases (23.27%) and T cell ALL with 27 cases (8.49%). Out of 222 patients, 17 (7.7%) had genetic abnormalities, with the highest incidence of abnormalities being associated with Runx 1 (four cases). Additionally, out of 228 patients, 143 (62.7%) were identified as having cytogenetic abnormalities, with the most prevalent abnormalities being hyperdiploidy (54 cases) and t (12;21) (28 cases).

Conclusion

Our findings showed that some cytogenetic abnormalities, such as t (9;22) and hyperdiploidy, were consistent with previous studies. These results offer valuable foundational insights that can help direct future research on ALL patients and inform potential treatment strategies.

Loading

Article metrics loading...

/content/journals/chddt/10.2174/011871529X372625250606123726
2025-06-19
2025-09-25
Loading full text...

Full text loading...

References

  1. He J. Munir F. Catueno S. Connors J.S. Gibson A. Robusto L. McCall D. Nunez C. Roth M. Tewari P. Garces S. Cuglievan B. Garcia M.B. Biological markers of high-risk childhood acute lymphoblastic leukemia. Cancers 2024 16 5 858 10.3390/cancers16050858 38473221
    [Google Scholar]
  2. Tebbi C.K. Etiology of acute leukemia: A review. Cancers 2021 13 9 2256 34066700
    [Google Scholar]
  3. Siegel R.L. Miller K.D. Fuchs H.E. Jemal A. Cancer statistics, 2022. CA Cancer J. Clin. 2022 72 1 7 33 10.3322/caac.21708 35020204
    [Google Scholar]
  4. Patel A.A. Thomas J. Rojek A.E. Stock W. Biology and treatment paradigms in T cell acute lymphoblastic leukemia in older adolescents and adults. Curr. Treat. Options Oncol. 2020 21 7 57 10.1007/s11864‑020‑00757‑5 32468488
    [Google Scholar]
  5. Greaves M.F. Maia A.T. Wiemels J.L. Ford A.M. Leukemia in twins: Lessons in natural history. Blood 2003 102 7 2321 2333 10.1182/blood‑2002‑12‑3817 12791663
    [Google Scholar]
  6. Clarkson B. Boyse E. Possible explanation of the high concoddance for acute leukaemia in monozygotic twins. Lancet 1971 297 7701 699 701 10.1016/S0140‑6736(71)92705‑X 4101637
    [Google Scholar]
  7. Stieglitz E. Loh M.L. Genetic predispositions to childhood leukemia. Ther. Adv. Hematol. 2013 4 4 270 290 10.1177/2040620713498161 23926459
    [Google Scholar]
  8. Andersen M.K. Christiansen D.H. Jensen B.A. Ernst P. Hauge G. Pedersen-Bjergaard J. Therapy‐related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: Report on two new cases and review of the literature since 1992. Br. J. Haematol. 2001 114 3 539 543 10.1046/j.1365‑2141.2001.03000.x 11552977
    [Google Scholar]
  9. Pui C.H. Nichols K.E. Yang J.J. Somatic and germline genomics in paediatric acute lymphoblastic leukaemia. Nat. Rev. Clin. Oncol. 2019 16 4 227 240 10.1038/s41571‑018‑0136‑6 30546053
    [Google Scholar]
  10. Li X. Li J. Hu Y. Xie W. Du W. Liu W. Li X. Chen X. Li H. Wang J. Zhang L. Huang S. A comprehensive cytogenetic classification of 1466 Chinese patients with de novo acute lymphoblastic leukemia. Leuk. Res. 2012 36 6 720 726 10.1016/j.leukres.2011.12.016 22264634
    [Google Scholar]
  11. Behjati F Akbari MT Chromosomal abnormalities in leukemia in Iran: A pilot study. 2001
    [Google Scholar]
  12. Pérez-Vera P. Mújica-Sánchez M. Carnevale A. Rivera-Luna R. Paredes R. Martínez A. Frías S. Cytogenetics in acute lymphoblastic leukemia in Mexican children: An institutional experience. Arch. Med. Res. 2001 32 3 202 207 10.1016/S0188‑4409(01)00260‑0 11395185
    [Google Scholar]
  13. Safaei A. Shahryari J. Farzaneh M.R. Tabibi N. Hosseini M. Cytogenetic findings of patients with acute lymphoblastic leukemia in fars province. Iran. J. Med. Sci. 2013 38 4 301 307 24293783
    [Google Scholar]
  14. Reddy P. Shankar R. Koshy T. Radhakrishnan V. Ganesan P. Jayachandran P.K. Dhanushkodi M. Mehra N. Krupashankar S. Manasa P. Nagare R.P. Swaminathan R. Kannan K. Sagar T.G. Ganesan T.S. Evaluation of cytogenetic abnormalities in patients with acute lymphoblastic leukemia. Indian J. Hematol. Blood Transfus. 2019 35 4 640 648 10.1007/s12288‑019‑01123‑8 31741615
    [Google Scholar]
  15. Paridar M. Ghalesardi O.K. Seghatoleslami M. Ahmadzadeh A. Khosravi A. Saki N. Cytogenetic and molecular basis of BCR-ABL myelodysplastic syndrome: Diagnosis and prognostic approach. J. Cancer Metastasis Treat. 2017 3 2 38 44 10.20517/2394‑4722.2016.61
    [Google Scholar]
  16. Akkari Y.M.N. Baughn L.B. Dubuc A.M. Smith A.C. Mallo M. Dal Cin P. Diez Campelo M. Gallego M.S. Granada Font I. Haase D.T. Schlegelberger B. Slavutsky I. Mecucci C. Levine R.L. Hasserjian R.P. Solé F. Levy B. Xu X. Guiding the global evolution of cytogenetic testing for hematologic malignancies. Blood 2022 139 15 2273 2284 10.1182/blood.2021014309 35167654
    [Google Scholar]
  17. Paridar M. Zibara K. Ahmadi S.E. Khosravi A. Soleymani M. Azizi E. Ghalesardi O.K. Clinico-Hematological and cytogenetic spectrum of adult myelodysplastic syndrome: The first retrospective cross-sectional study in Iranian patients. Mol. Cytogenet. 2021 14 1 24 10.1186/s13039‑021‑00548‑z 33964952
    [Google Scholar]
  18. Rahimi Pordanjani S. Kavousi A. Mirbagheri B. Shahsavani A. Etemad K. Geographical pathology of acute lymphoblastic leukemia in Iran with evaluation of incidence trends of this disease using Joinpoint regression analysis. Arch. Iran Med. 2021 24 3 224 232 10.34172/aim.2021.34 33878881
    [Google Scholar]
  19. Tlacuilo-Parra A. Garibaldi-Covarrubias R. Romo-Rubio H. Soto-Sumuano L. Ruiz-Chávez C.F. Suárez-Arredondo M. Sánchez-Zubieta F. Gallegos-Castorena S. Geographical distribution and cluster detection of childhood leukemia in the metropolitan area of Guadalajara, Mexico. Rev. Invest. Clin. 2017 69 3 159 165 10.24875/RIC.17002131 28613286
    [Google Scholar]
  20. Bahoush G. Nojoomi M. Frequency of cytogenetic findings and its effect on the outcome of pediatric acute lymphoblastic leukemia. Med. Arh. 2019 73 5 311 315 10.5455/medarh.2019.73.311‑315 31819303
    [Google Scholar]
  21. Lustosa de Sousa D.W. de Almeida Ferreira F.V. Cavalcante Félix F.H. de Oliveira Lopes M.V. Acute lymphoblastic leukemia in children and adolescents: Prognostic factors and analysis of survival. Rev. Bras. Hematol. Hemoter. 2015 37 4 223 229 10.1016/j.bjhh.2015.03.009 26190424
    [Google Scholar]
  22. Mehrvar A. Faranoush M. Asl A.A.H. Tashvighi M. Fazeli M.A. Mehrvar N. Epidemiological features of childhood acute leukemia at MAHAK’s Pediatric Cancer Treatment and Research Center (MPCTRC), Tehran, Iran., 2015 7 1 9 15
    [Google Scholar]
  23. Dastgiri S. Fozounkhah S. Shokrgozar S. Taghavinia M. Asvadi Kermani A. Incidence of leukemia in the northwest of iran. Health Promot. Perspect. 2011 1 1 50 53 10.5681/hpp.2011.004 24688899
    [Google Scholar]
  24. Gu Z. Churchman M.L. Roberts K.G. Moore I. Zhou X. Nakitandwe J. Hagiwara K. Pelletier S. Gingras S. Berns H. Payne-Turner D. Hill A. Iacobucci I. Shi L. Pounds S. Cheng C. Pei D. Qu C. Newman S. Devidas M. Dai Y. Reshmi S.C. Gastier-Foster J. Raetz E.A. Borowitz M.J. Wood B.L. Carroll W.L. Zweidler-McKay P.A. Rabin K.R. Mattano L.A. Maloney K.W. Rambaldi A. Spinelli O. Radich J.P. Minden M.D. Rowe J.M. Luger S. Litzow M.R. Tallman M.S. Racevskis J. Zhang Y. Bhatia R. Kohlschmidt J. Mrózek K. Bloomfield C.D. Stock W. Kornblau S. Kantarjian H.M. Konopleva M. Evans W.E. Jeha S. Pui C.H. Yang J. Paietta E. Downing J.R. Relling M.V. Zhang J. Loh M.L. Hunger S.P. Mullighan C.G. PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia. Nat. Genet. 2019 51 2 296 307 10.1038/s41588‑018‑0315‑5 30643249
    [Google Scholar]
  25. Raboso-Gallego J. Casado-García A. Isidro-Hernández M. Vicente-Dueñas C. Epigenetic priming in childhood acute lymphoblastic leukemia. Front. Cell Dev. Biol. 2019 7 137 10.3389/fcell.2019.00137 31380372
    [Google Scholar]
  26. Pui C.H. Carroll W.L. Meshinchi S. Arceci R.J. Biology, risk stratification, and therapy of pediatric acute leukemias: An update. J. Clin. Oncol. 2011 29 5 551 565 10.1200/JCO.2010.30.7405 21220611
    [Google Scholar]
  27. Dastugue N. Suciu S. Plat G. Speleman F. Cavé H. Girard S. Bakkus M. Pagès M.P. Yakouben K. Nelken B. Uyttebroeck A. Gervais C. Lutz P. Teixeira M.R. Heimann P. Ferster A. Rohrlich P. Collonge M.A. Munzer M. Luquet I. Boutard P. Sirvent N. Karrasch M. Bertrand Y. Benoit Y. Hyperdiploidy with 58-66 chromosomes in childhood B-acute lymphoblastic leukemia is highly curable: 58951 CLG-EORTC results. Blood 2013 121 13 2415 2423 10.1182/blood‑2012‑06‑437681 23321258
    [Google Scholar]
  28. Amare P.S.K. Jain H. Kabre S. Deshpande Y. Pawar P. Banavali S. Menon H. Sengar M. Arora B. Khattry N. Narula G. Sarang D. Kaskar S. Bagal B. Jain H. Dangi U. Subramanian P.G. Gujral S. Cytogenetic profile in 7209 Indian patients with de novo acute leukemia: A single centre study from India. J. Cancer Ther. 2016 7 7 530 544 10.4236/jct.2016.77056
    [Google Scholar]
  29. Jabber Al-Obaidi M.S. Martineau M. Bennett C.F. Franklin I.M. Goldstone A.H. Harewood L. Jalali G.R. Prentice H.G. Richards S.M. Roberts K. Harrison C.J. ETV6/AML1 fusion by FISH in adult acute lymphoblastic leukemia. Leukemia 2002 16 4 669 674 10.1038/sj.leu.2402435 11960348
    [Google Scholar]
  30. Grossmann V. Kern W. Harbich S. Alpermann T. Jeromin S. Schnittger S. Haferlach C. Haferlach T. Kohlmann A. Prognostic relevance of RUNX1 mutations in T-cell acute lymphoblastic leukemia. Haematologica 2011 96 12 1874 1877 10.3324/haematol.2011.043919 21828118
    [Google Scholar]
  31. Ito Y. Oncogenic potential of the RUNX gene family: ‘Overview’. Oncogene 2004 23 24 4198 4208 10.1038/sj.onc.1207755 15156173
    [Google Scholar]
  32. Wong W.F. Kohu K. Chiba T. Sato T. Satake M. Interplay of transcription factors in T-cell differentiation and function: The role of Runx. Immunology 2011 132 2 157 164 10.1111/j.1365‑2567.2010.03381.x 21091910
    [Google Scholar]
/content/journals/chddt/10.2174/011871529X372625250606123726
Loading
/content/journals/chddt/10.2174/011871529X372625250606123726
Loading

Data & Media loading...


  • Article Type:
    Research Article
Keywords: Genetic abnormalities ; hematologic neoplasms ; Iran ; acute lymphoid leukemia ; cytogenetics
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test